CRL CEVP Shannon Parisotto Exercises Options and Sells 3,714 Shares
$CRL · CHARLES RIVER LABORATORIES INTERNATIONAL, INC.Research Summary
AI-generated summary of this SEC filing
CRL CEVP Shannon Parisotto Exercises Options and Sells 3,714 Shares
What Happened
Shannon M. Parisotto, CEVP, Discovery & Safety Assessment at Charles River Laboratories (CRL), exercised 3,714 option shares at $179.66 per share (cost $667,257) on 2026-08-11 and immediately sold those 3,714 shares in the open market at $279.66 per share for gross proceeds of $1,038,657. A related derivative instrument was disposed of at exercise (reported at $0.00).
Key Details
- Transaction date: 2026-08-11; Form 4 filed 2026-08-13 (timely within the 2-business-day reporting window).
- Exercise: 3,714 shares at $179.66 — total exercise cost $667,257.
- Sale: 3,714 shares at $279.66 — gross proceeds $1,038,657.
- Net proceeds before taxes/fees (sale minus exercise cost): $371,400.
- Footnote: Transactions occurred pursuant to a Rule 10b5-1 trading plan adopted March 4, 2026.
- Shares owned after the transaction: Not specified in the provided filing.
Context
This was a same-day exercise and sale (a cashless-style outcome): the options were exercised and the underlying shares were immediately sold in the open market. The trade was executed under a pre-established 10b5-1 plan, which typically sets the timing and terms in advance and is a commonly used mechanism for scheduled insider sales. The filing appears timely and does not by itself indicate the insider’s future view of company prospects.